CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $76,000 | -85.6% | 51,992 | -80.7% | 0.04% | -35.5% |
| Q4 2019 | $529,000 | -61.7% | 270,017 | 0.0% | 0.06% | -65.0% |
| Q3 2019 | $1,382,000 | -20.3% | 270,017 | +11.5% | 0.18% | +47.5% |
| Q2 2019 | $1,734,000 | -28.9% | 242,200 | +31.8% | 0.12% | +6.2% |
| Q1 2019 | $2,440,000 | +149.5% | 183,800 | +47.9% | 0.11% | +68.7% |
| Q4 2018 | $978,000 | +3160.0% | 124,300 | +1000.0% | 0.07% | +1575.0% |
| Q2 2015 | $30,000 | -92.8% | 11,300 | -81.3% | 0.00% | -93.1% |
| Q1 2015 | $417,000 | – | 60,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |